[Vitaprost Forte in the treament of patients with benign prostatic hyperplasia: pathogenetic basics and clinical results].
The review is dedicated to the history of creation, biological effects and clinical use of prostatic peptides. Pathogenetic basics of using peptide drugs in prostatic disease are discussed. The results of clinical trials of efficiency of drug Vitaprost Forte in patients with benign prostatic hyperplasia are shown.